Futura Medical PLC (LSE:FUM) - Share price - Overview


Stock Report

Futura Medical PLC FUM

Last Price
GBX17.25

Day Change
0.75|4.55%

As of 18/04/2019
16:29:44 BST | GBX
Minimum 15 Minutes Delay.

Last Close16.50p
Day Range16.50 - 17.50
Mkt Cap33.77Mil
52-Wk Range5.65 - 42.26
Yield %-
ISINGB0033278473
Volume719,942
P/E-5.37
P/S0.58
P/CF-0.05

Share Price

Total Returns 17/04/2019

 Chg (%)  
More ...
Futura Medical PLC10.00 
FTSE 100 TR GBP2.67
 
Financials
201520162017
More ...
Income Statement
Turnover0.030.170.36
Operating Profit-6.12-4.55-4.86
Net Profit-5.08-3.70-3.90
Reported EPS-5.10-3.63-3.21
Balance Sheet
Current Assets5.5013.429.54
Non Current Assets0.020.020.06
Total Assets5.5213.449.61
Current Liabilities0.730.860.50
Total Liabilities---
Total Equity4.7912.589.11
Cash Flow
Operating Cash Flow-5.85-4.30-5.03
Net Change in Cash-5.308.17-3.99
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
11/01/2019PurchaseMr. John Milne Clarke25.1057,25014,370.00
11/01/2019PurchaseMr. Jonathan David Freeman25.1019,5784,914.00
13/11/2018PurchaseMr James Henry Barder7.00357,14225,000.00
13/11/2018PurchaseMr. Jonathan David Freeman7.007,478523.00

Company Profile

Futura Medical PLC is a UK based drug manufacturer. Its business is to manufacture pharmaceutical products mainly for the treatment of erectile dysfunction and a measure against pain relief.

Sector

Drug Manufacturers - Major

Index

FTSE AIM All-Share

Next Event 24/04/2019

Annual Report
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-53.33
Op Mrgn-13.39
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanMr. John Milne Clarke
Executive Director, Chief ExecutiveMr James Henry Barder
Non-Executive DirectorMr. Jonathan David Freeman
Executive Director, Head of RandDMr. Kenneth William James
Executive Director, Finance Director and Chief Operating OfficerAngela Hildreth
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.